@article{7772ac0aa30f4b76ab8a4da0cadf9dbc,
title = "Changes in treatment of community-onset Clostridioides difficile infection after release of updated guidelines, Atlanta, Georgia, 2018",
abstract = "Updated Clostridioides difficile infection (CDI) guidelines published in 2018 recommend vancomycin as first-line treatment. Of 833 community-onset CDI cases in metropolitan Atlanta, Georgia in 2018, over half did not receive first-line treatment, although guideline adherence increased over the year. Second-line treatment was more common in patients treated in ambulatory settings.",
keywords = "Clostridioides difficile infection, Guideline-adherent treatment, Metronidazole, Vancomycin",
author = "Adelman, {Max W.} and Dana Goodenough and Samantha Sefton and Carolyn Mackey and Stepy Thomas and Fridkin, {Scott K.} and Woodworth, {Michael H.}",
note = "Funding Information: Georgia Emerging Infections Program surveillance was funded through the Centers for Disease Control and Prevention under U50CK000485 . This research was also supported in part by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number K23AI144036 to MHW. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Centers for Disease Control and Prevention or the National Institutes of Health. Publisher Copyright: {\textcopyright} 2021 Elsevier Ltd",
year = "2021",
month = aug,
doi = "10.1016/j.anaerobe.2021.102364",
language = "English (US)",
volume = "70",
journal = "Anaerobe",
issn = "1075-9964",
publisher = "Academic Press",
}